Hims and Hers Health is planning to cash in on Novo Nordisk losing its semaglutide drug exclusivity in Canada. The telehealth ...

Dallas Wings Make Decision on Paige Bueckers After Coach's Crucial Update on Her Health originally appeared on Athlon Sports.

Shares of telehealth company Hims & Hers Health (NYSE:HIMS) jumped 4.1% in the morning session after the company announced ...

In PEOPLE’s exclusive clip from Tuesday’s season finale of 1000-Lb. Roomies, Jaz has a serious conversation about their health. After undergoing weight-loss surgery, Jaz suffered an unexpected fall ...

Hims & Hers Health reports 111% Q1 2025 revenue growth to $586M, driven by personalized treatments & strong margins. Read why ...

Hims & Hers announced plans to expand its weight loss program to Canada in 2026 in connection with the availability of generic semaglutide anywhere in the world.

Hims & Hers Health plans to expand into Canada, timing it with the new availability of the generic weight loss medication on the market for the first time.

Novo Nordisk will lose its patent protection on its branded semaglutide drugs Ozempic and Wegovy in Canada after not paying a ...

The move follows a dramatic breakup in June between Hims & Hers and Danish drug maker Novo Nordisk, which makes the brand name weight loss drug Wegovy. Novo Nordisk accused the Hims & Hers of ...

Keeping Up With the Kardashians' star Khloé Kardashian has been open about her health journey over the years. Here's ...

ChatGPT can be dangerous to use in place of a therapist, but people are finding ways it supplements therapy and helps them ...

Hims & Hers Health, Inc. (HIMS) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want ...